Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Microarray patches enable the development of skin-targeted vaccines against COVID-19

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.01.022Source: DataRank Database

Microarray patches enable the development of skin-targeted vaccines against COVID-19 is a research paper published in Advanced Drug Delivery Reviews (2021). On theSindex it has a DataRank of 0. It has been cited 61 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access61 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 4.34)OA: hybridTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Stephen C. Balmert ORCID,Tina L. Sumpter ORCID,Cara Donahue Carey ORCID,Géza Erdös ORCID,Louis D. Falo ORCID

Live enrichment

PubMed:33539853 PMC:PMC8060128 OpenAlex:https://openalex.org/W3127098266

UPMC Enterprises

Grant: IPA 25565

National Institutes of Health

Grant: R01- AR074285

National Institutes of Health

Grant: UM1-AI106701

National Institutes of Health

Grant: R01-AR071277

NIAMS NIH HHS

Grant: R01 AR074285

NIAMS NIH HHS

Grant: R01 AR079233

NIAMS NIH HHS

Grant: R01 AR071277

NIAID NIH HHS

Grant: UM1 AI106701

National Institutes of Health

FWCI

4.34

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S0169409X2100034X-ga1_lrg.jpg

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S0169409X2100034X-ga1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S0169409X2100034X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169409X2100034X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.addr.2021.01.022

Fields of Study

Advancements in Transdermal Drug DeliveryImmunotherapy and Immune ResponsesDermatology and Skin DiseasesAdministration, CutaneousCOVID-19COVID-19 VaccinesDrug DevelopmentHumansImmunity, InnateSARS-CoV-2SkinTransdermal Patch

MeSH Terms

Drug DevelopmentCOVID-19SARS-CoV-2COVID-19 VaccinesAdministration, CutaneousHumansImmunity, InnateSkinTransdermal Patch

Keywords

VaccinationImmunizationPandemicImmunologyImmune systemContext (archaeology)VirologyAntigenMedicineBiologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)DiseasePathologyInfectious diseasesSpike proteinprophylactic immunizationMicroarray PatchesCovid-19Sars-cov-2Cutaneous ImmunobiologySkin-targeted Vaccines

Sustainable Development Goals

SDG 0: Good health and well-being

Microarray patches enable the development of skin-targeted vaccines against COVID-19

FAIR Checklist

Authors (6)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)